Randomised phase II study of axitinib or bevacizumab combined with paclitaxel / carboplatin as fi rst-line therapy for patients with advanced non-small-cell lung cancer
暂无分享,去创建一个
J. Schiller | P. Bycott | C. Twelves | J. Williams | S. Popat | L. Havel | C. Chen | E. Chmielowska | A. Olszanski | S. Kim | A. Świeboda-Sadlej | A. Ingrosso | P. Sawrycki | P. Besi